# US 2015/0105359 A1 · Pharmaceutical composition for emergency contraception

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105359 A1
- Document ID: US20150105359A1
- Status: Published application
- Kind: A1
- Application number: 14/569,579
- Filed: 2014-12-12
- Published: 2015-04-16
- Earliest claimed: 2009-06-23
- Assignees: Bayer Intellectual Property GmbH
- Applicants: Bayer Intellectual Property GmbH
- Inventors: Bernhard LINDENTHAL; Rolf SCHÜRMANN; Sascha GENERAL
- Web page: https://patentgrep.com/patent/US20150105359A1

## CPC

- A61K 31/57: substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K 31/18: Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N- group A61K31/63)
- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 31/196: the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A61K 31/405: Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A61K 31/415: 1,2-Diazoles
- A61K 31/5415: ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A61K 31/542: ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/567: substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A61K 31/575: substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A61K 31/585: containing lactone rings, e.g. oxandrolone, bufalin
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 5/34: Gestagens
- A61P 15/18: Feminine contraceptives
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to pharmaceutical compositions for emergency contraception, to the use of levonorgestrel in combination with COX inhibitors for the preparation of pharmaceutical compositions for the stated purpose, and to a method for preparing these pharmaceutical compositions.

## Claims

### Claim 1

A pharmaceutical composition administered in a single dose comprising
(a) 50-900 μg levonorgestrel;
(b) a COX inhibitor selected from: 50-600 mg indomethacin and 40-50 mg diclofenac; and
(c) a pharmaceutically acceptable excipient.

### Claim 2 (depends on 1)

The pharmaceutical composition as claimed in claim 1, characterized in that the levonotgestrel is in a range of
100-360 μg.

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The pharmaceutical composition as claimed in claim 1, wherein the levonorgestrel is in a range of 150-300 μg.

### Claim 6 (depends on 1)

The pharmaceutical composition as claimed in claim 1, wherein the COX inhibitor is indomethacin.

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The pharmaceutical composition as claimed in claim 1, wherein the COX inhibitor is diclofenac.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

A method for emergency contraception comprising administering to a patient in need thereof the composition of claim 1.

### Claim 12 (depends on 9)

The method of claim 9, wherein the pharmaceutical composition is administered in a single dose within 72 hours post coitus.

### Claim 13

(canceled)
